Jasper Therapeutics, Inc.·4

Nov 2, 6:00 PM ET

WIGGANS THOMAS G 4

4 · Jasper Therapeutics, Inc. · Filed Nov 2, 2023

Insider Transaction Report

Form 4
Period: 2023-11-01
Transactions
  • Award

    Stock Option (right to buy)

    2023-11-01+110,000110,000 total
    Exercise: $0.69Exp: 2033-11-01Voting Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on November 1, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file
  • 4
    ownership.xmlPrimary